XML 74 R62.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stockholders Equity (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
May 31, 2024
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Apr. 05, 2024
Dec. 31, 2023
Aug. 05, 2020
Stock based compensation for stock options   $ 53,000 $ 0 $ 106,000 $ 0      
Shares reserved for grants   128,037   128,037        
Net of estimated forfeitures of approximately       12.00%        
Stock based compensation for grants totataling   $ 228,000 $ 212,000 $ 441,000 429,000      
Weighted average estimated fair value       $ 1.24        
Proceeds from sale       $ 168,190 $ 0      
Weighted-average vesting period       2 years 6 months 7 days        
Estimated fair value of unamortized compensation   280,000   280,000        
Exercise price   $ 1.00   $ 1.00        
Closing price of common stock   $ 5.00   $ 5.00        
Purchase of aggregate common stock outstanding       969,525        
Warrants issued to purchase common stock       969,525        
Stock option awards   $ 192,000   $ 192,000        
Common stock shares authorized   993,200   993,200        
Equity and debt securities registration amount           $ 50,000,000    
Common stock shares authorized   20,000,000   20,000,000     20,000,000  
Sales Agreement [Member]                
Offering price $ 16,400,000              
Common Stock shares sold   56,109            
Weighted average price   $ 4.84   $ 4.84        
Proceeds from sale   $ 167,629            
Remaining capacity to sell additional common stock   $ 16,128,423   $ 16,128,423        
10 May 2023 [Member]                
Common stock shares authorized   1,900,000   1,900,000        
Held-to-Maturity Securities US Treasury Securities [Member]                
Common stock shares authorized   700,000   700,000       1,400,000